2010 Cancer Report
2010 Cancer Report — Cancer Site Analysis of Lung Cancer
- Cancer Program review for 2010
- Summary of Cancer Registry data for 2009
- Cancer Site Distribution for 2009
- 2009 Lung Cancer Study presented by M. Koshy, MD
- Role of the MMH Cancer Registry
Our Cancer Program
The Oncology Committee of Manatee Memorial Hospital is pleased to present this report of MMH Cancer Program activities during 2010. Except where expressly noted, the Cancer Registry data in this report is from 2009. The Commission on Cancer (CoC) has approved the MMH cancer program as a Community Hospital Cancer Program (CHCP). To achieve approval status a facility must show that its patients have access to all major modalities of cancer treatment, either on-site or by referral, and meet national standards for multidisciplinary interaction by the entire cancer care team. Besides cancer diagnostic, staging and treatment modalities, these standards require ongoing performance improvement, demonstration of adherence to quality measures, outcomes analyses, staff education, patient support services and community outreach activities.
In 2009 the MMH Cancer Program activities included the following highlights:
- Implementation of a three-part labeling system to avoid errors on high-risk drugs
- An additional monthly Cancer Conference that focuses strictly on breast cancer
- Implementation of a "No One Dies Alone" program to assure that none of our patients are without companionship during the end stage of illness/life
- Implementation of quarterly "Open Patient Safety Forums" to improve patient safety through continuous dialect between all patient care providers
- Monthly session on tobacco prevention and cessation awareness held at MMH
- Breast cancer awareness activities in October
- Public forums discussing topics such as "Breast & Ovarian Cancer Screening" and "da Vinci Surgery: The New Era of Surgical Techniques for Gynecological Cancer"
The success of the above only exists through the extraordinary day-to-day cancer patient care activities. MMH believes that providing the best possible cancer care lies with each professional individual member providing quality care and support to our cancer patients.
MMH frequently collaborates with the American Cancer Society, the American Lung Association, the Manatee County Health Department and the Wellness Community to provide cancer support, cancer screenings and educational services to the local cancer patient population.
Summary of Cancer Registry Data for 2009
A total of 653 new cancer patients were treated at MMH during 2009. Of these, 541 (82%) were analytic (newly diagnosed) and 112 (18%) were non-analytic (diagnosed and completed first-course therapy elsewhere). Since January 1, 2004, cancer registries have been required by federal and state legislation to also collect and report benign brain tumors.
The demographic (sex, race, age) distributions of our analytical cancer patient populations are important for planning effective cancer services. This information can provide MMH insight in identifying what additional services such as treatment modalities and support services are needed in the community. In 2009, the sex distribution was 68% female cancer patients and 52% male cancer patients. This represents a significant increase from the prior year in the female cancer patients (58%). The racial distribution was 91% white, 7% black and 2% other races. This represents a slight decrease from the prior year in white race (93%) and slight increase in black race (6%) and other race (1%). The largest age group diagnosed with cancer were patients 70 years or older, who represent 48% of our 2009 cancer cases.
Determining the stage or extent of cancer is critical to making effective treatment decisions. The staging system used for this report is the Collaborative Staging System (CSS) developed by the American Joint Committee on Cancer (AJCC), the Commission on Cancer (CoC), and the Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Institute with collaboration from multiple national and state cancer organizations. The CSS staging system uses an algorithm to derive from staging factors collected by cancer registries a stage that may combine clinical and pathologic tumor (T), lymph node (N) and metastatic (M) components. The overall AJCC stage distribution of MMH analytic cancer cases is as follows:
- Stage 0 – 6%
- Stage 1 – 24%
- Stage 2 – 13%
- Stage 3 – 11%
- Stage 4 – 15%
- Stage Unknown – 20%
- Stage Not Applicable – 11%
Stage distributions for specific primary sites can be found on the MMH site distribution table:
The five most frequent sites of cancer seen at MMH during 2009 were breast (26%), lung (17%), colorectal (12%), uterus (7%) and bladder (4%). Per Cancer Facts & Figures 2009, published by the American Cancer Society, the five most common cancers in the United States were lung, breast, prostate, colorectal and bladder, respectively. Per the same source, the most common cancers in Florida were lung, breast, prostate, colorectal and bladder, respectively. A chart comparing the frequency of cancer sites seen at MMH in 2009 compared to national and Florida incidence follows: